Cancer research has come a long way over the past few decades. Tailored therapies, understanding lifestyle factors and insight into how tumors work on a molecular level, among other areas of research, have led to an overall decrease in the rate of cancer deaths.
Clinical trials are research studies designed to answer questions about new ways to diagnose, treat and prevent cancer. Clinical trial participants have the opportunity to receive new research treatments before they are widely available and help others by contributing to medical research. Trials are essential to develop new treatments for cancer. Learn more about Clinical trials at Levine Cancer Institute here.
Clinical trials currently available at Levine Cancer Institute-Blue Ridge are:
1) ASCO TAPUR: The Targeted Agent and Profiling Utilization Therapy Study - To learn more search keyword ASCO at this location.
2) LCI – SPEC-REG-002: Collection of Specimens and Data on Patients with Molecular Tumor Testing - To learn more search keyword SPEC-REG-002 at this location.
3) LCI – BRE-H2n-ANPA-001: Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast Cancer - To learn more search keyword ANPA-001 at this location.
For More Information
Call for more information about clinical trials at Levine Cancer Institute-Blue Ridge: 828-580-7285